Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Rare disease

Pulmonary arterial hypertension

  • 38 clinical trials
Quick filters

38 Clinical trials

Pulmonary arterial hypertension

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years

Pulmonary arterial hypertension

Recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:HUMAN IGG4 KAPPA MONOCLONAL ANTIBODY AGAINST PLATELET-DERIVED GROWTH FACTOR SUBUNIT B
  • Sponsor:Regeneron Pharmaceuticals Inc.

Pulmonary arterial hypertension

Recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:ROC-101 HYDROCHLORIDE
  • Sponsor:Allrock Bio Inc.

Pulmonary arterial hypertension

Recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Ltp001
  • Sponsor:Novartis Pharma AG

Pulmonary arterial hypertension

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ambrisentan
  • Sponsor:Assistance Publique Hopitaux De Paris

Heritable pulmonary arterial hypertension+1

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Sotatercept
  • Sponsor:Amsterdam UMC Stichting
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.